Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm is engaged in designing, developing, and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk again. The firm offers an exoskeleton that uses its tilt-sensor technology and an onboard computer and motion sensors to drive motorized legs that power movement. Lifeward designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The firm offers multiple products: ReWalk Personal, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities and is custom-fitted for each user. Lifeward Rehabilitation products are for use by paraplegia patients in the clinical rehabilitation environment.
Follow-Up Questions
Lifeward Ltd의 CEO는 누구입니까?
Mr. Mark Grant은 2025부터 회사에 합류한 Lifeward Ltd의 President입니다.
LFWD 주식의 가격 성능은 어떻습니까?
LFWD의 현재 가격은 $0.7322이며, 전 거래일에 increased 6.3% 하였습니다.
Lifeward Ltd의 주요 사업 주제나 업종은 무엇입니까?
Lifeward Ltd은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
Lifeward Ltd의 시가총액은 얼마입니까?
Lifeward Ltd의 현재 시가총액은 $11.4M입니다
Lifeward Ltd는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 4명의 분석가가 Lifeward Ltd에 대한 분석 평가를 실시했으며, 이는 2명의 강력한 매수, 5명의 매수, 1명의 보유, 0명의 매도, 그리고 2명의 강력한 매도를 포함합니다
